Safety of an oral chondroprotective agent in horses

Veterinary Therapeutics

Volumn 2, Issue 4, 2001, Pages 345-353

  Kirker Head, Carl A ^a   Kirker Head, Romona P ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLUCOSAMINE; MANGANESE;

ANIMAL; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HORSE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; CHONDROITIN SULFATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; GLUCOSAMINE; HORSES; MANGANESE;

EID: 0038017576     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. nd ed. St. Louis: Mosby; 1990:665-668.
2. Glade MJ: Chronic dexamethasone treatment of horse and pony foals. Dissertation Abstr Int 41 B(1):6-7, 1980.
3. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L: Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 23(8):1385-1391, 1996.
4. Verbruggen G, Goemaere S, Veys EM: Chondroitin sulfate: S/DMOAD (structure/disease modifying antiarthritis drug) in the treatment of finger joint osteoarthritis. Osteoarthritis Cartilage 6(Suppl A):37-38, 1998.
5. Uebelhart D, Thonar EJ, Zhang J, Williams JM: Protective effect of chondroitin 4,6 sulfate in the acute degeneration of articular cartilage in the rabbit. Osteoarthritis Cartilage 6(Suppl A):6-13, 1998.
6. Uebelhart D, Thonar EJMA, Delmus PD, Chantraine A, Vignon E: Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: A pilot study. Osteoarthritis Cartilage 6(Suppl A):39-46, 1998.
7. Mourao PA, Giumaraes B, Mulloy B, Thomas S, Gray E: Antithrombotic activity of a fucosylated chondroitin sulphate from echinoderm: Sulfated fucose branches on the polysaccharide account for its antithrombotic action. Br J Haematol 101(4):647-652, 1998.
8. Fenton JI, Chlebek-Brown KA, Peters TL, Caron JP, Orth MW: Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 8:258-265, 2000.
9. Grande D, O'Grady C, Garone E, Lippiello L, Marwin S: Chondroprotective and gene expression effects of nutritional supplements on articular cartilage. Osteoarthritis Cartilage 8(Suppl B):S34-S35, 2000.
10. Lippiello, L, Woodward J, Karpman R, Hammad T: In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop 381:229-240, 2000.
11. Canapp SO, McLaughlin RM, Hoskinson JJ, Roush JK, Butine MD: Scintigraphic evaluation of glucosamine HCl and chondroitin sulfate as treatment for acute synovitis in dogs. Am J Vet Res 60(12):1550-1556, 1999.
12. Anderson MA, Slater MR, Hammad TA: Results of a survey of small animal practitioners on the perceived clinical efficacy and safety of an oral nutraceutical. Prev Vet Med 38(1):65-73, 1999.
13. th Annu Conf Vet Orthop Soc: 64, 1998.
14. Beren J, Hill S, Diener-West M, Rose N: The effects of pre-loading oral glucosamine HCl/chondroitin sulfate/manganese ascorbate combination on experimental arthritis in rats. Exp Biol Med 226(2):144-152, 2001.
15. Johnson KA, Hulse DA, Hart RC, Kochevar D, Chu Q: Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride, and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transaction model of osteoarthritis. Osteoarthritis Cartilage 9(1):14-21, 2001.
16. Leffler CT, Philippi AF, Leffler SG, Mosure JC, Kim PD: Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: A randomized, double-blind, placebo-controlled pilot study. Mil Med 164(2):85-91, 1999.
17. Das AK, Hammad TA: Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate, and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 8(5):343-350, 2000.
18. Hanson RR, Smalley LR, Huff GK, White S, Hammad TA: Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Pract 19(9):16-22, 1997.
19. Hanson RR, Brawner WR, Blaik MA, Hammad TA, Kincaid SA, Pugh DG: Oral treatment with a nutraceutical (Cosequin®) for ameliorating signs of navicular syndrome in horses. Vet Ther 2(2):148-159, 2001.
20. Downer J, Blanchard K: Nutraceuticals for your pet. DSHEA, which governs human dietary supplements, does not apply to animals. J Am Nutraceutical Assoc 2(3):19-22, 2000.
21. Davidson G: Glucosamine and chondroitin sulfate. Compend Contin Educ Pract Vet 22(5):454-458, 2000.
22. McNamara PS, Barr SC, Erb HN: Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 57(9):1390-1394, 1996.
23. McNamara PS, Barr SC, Erb HN, Barlow LL: Hematologic, hemostatic, and biochemical effects in cats receiving an oral chondroprotective agent for 30 days. Vet Ther 1(2):108-117, 2000.
24. Van Pelt RW: Interpretation of synovial fluid findings in the horse. JAVMA 165:91-95, 1974.
25. Adebowale A, Cox D, Liang Z, Eddington ND: Analysis of glucosamine and chondroitin sulfate content in marketed products and the caco-2 permeabilily of chondroitin sulfate raw materials. J Am Nutraceutical Assoc 3(1):37-44, 2000.
26. Way W, Gibson K, Breite A: Determination of chondroitin sulfate in nutritional supplements by liquid chromatography. J Liquid Chromatogr & Related Technol 23(18):2851-2860, 2000.
27. Way W, Gibson K, Breite A: Determination of glucosamine in nutritional supplements by reverse-phase ion-pairing HPLC. J Liquid Chromatogr & Related Technol 23(18):2861-2871, 2000.
28. nd ed. St. Louis: Mosby; 1990:386-414.
29. Ronca F, Palmieri L, Panucucci P, Ronca G: Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 6(Suppl A):14-21, 1998.
30. Conte A, Volpi N, Palmiera L, Bahous I, Ronca G: Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Drug Res 45(8):918-925, 1995.
31. Setnikar I, Giacchetti C, Zanolo G: Pharmacokinetics of glucosamine in dog and in man. Arzneim Forsch/Drug Res 36(4):729-734, 1986.
32. Liang Z, Leslie J, Adebowale A, Ashraf M, Eddington ND: Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms, and plasma using pre-column derivatization with ultraviolet HPLC. J Pharm Biomed Anal 20(5):807-814, 1999.
33. Eddington ND, Du J, White N: Evidence of the oral absorption of chondroitin sulfate as determined by total disaccharide content after oral and IV administration to horses. 2001 Annu Conv AAEP, accepted for presentation, 2001.